GlobalData on MSN4d
Globus Medical strengthens SCS market position with $250m Nevro deal
GlobalData senior medical device analyst says the acquisition could see Nevro’s growth outside the US accelerate.
Hosted on MSN25d
Will Globus Medical (GMED) Beat Estimates Again in Its Next Earnings Report?
For the last reported quarter, Globus Medical came out with earnings of ... Estimate is a version of the Zacks Consensus whose definition is related to change. The idea here is that analysts ...
Business Insider16d
Alterity Therapeutics Announces Positive ATH434 Phase 2 Trial Results in Multiple System Atrophy Led By Robust Clinical Efficacy
Regarding iron content by MRI, the 50 mg dose reduced iron accumulation in MSA affected brain regions (substantia nigra, putamen, and globus pallidus ... Professor of Neurology at Vanderbilt ...
BMJ12d
Differences in globus pallidus neuronal firing rates and patterns relate to different disease biology in children with dystonia
We report microelectrode data from the globus pallidus interna (GPi ... Dystonia Society UK, Action Medical Research, German National Academic Foundation. This was a retrospective analysis of ...
Mena FN22d
Appendix 4C – Q2 FY25 Quarterly Cash Flow Report
Claassen, M.D., M.S., Professor of Neurology, Vanderbilt University Medical Center at the MDS meeting ... the MSA patients exhibited significant volume reductions in the cerebellum, globus pallidus, ...
Globus Medical, Inc. (NYSE:GMED) Stake Lowered by State of Alaska Department of Revenue
State of Alaska Department of Revenue reduced its stake in shares of Globus Medical, Inc. (NYSE:GMED – Free Report) by 1.2% ...